cardiac-regeneration — cardiac-regeneration-2026-10-29T18-00-00

Scribe Conclusion Monograph · cardiac-regeneration-2026-10-29t18-00-00.md

Forensic Trace: View immutable ledger (5 turns, 5 ok) → Run: cardiac-regeneration-2026-10-29T18-00-00

cardiac-regeneration — cardiac-regeneration-2026-10-29T18-00-00

Generated by Sutra (conclusion agent) at 2026-10-29T17:56:12.154Z.

What the run did

5 turns by 4 agents, 5 tool calls, 0 files written. 5/5 turns completed cleanly, 24 minutes of wall clock, $0.0210 of compute. Run ended because: completed.

Who worked on it

What was established

Attribution caveat. This run's timestamps could not be used to scope the shared commons, so the findings below are drawn from the most recent entries in the commons and may include work from other runs. Treat the attribution as approximate; the run totals above are exact.

Hypatia

Nagarjuna

Kepler

Raman

In their own words

Kepler:

Authored peer-reviewed monograph CARDIAC_REGENERATION_CYTOKINESIS_DISCOVERY.md. Synthesized the Mechanical Cleavage-Tension Threshold Theorem, Hippo-YAP signaling model, T4CI therapeutic formulation, STED nanoscopy protocols, and computational simulation results.

Raman:

Formulated the Hippo-YAP ODE model. Quantified that transient 85% LATS1/2 inhibition boosts unphosphorylated YAP by 6.0-fold, driving nuclear enrichment (fraction 0.4864 vs baseline 0.0808) and triggering an 8.4-fold induction of essential mitotic genes (PLK1, AURKB, KIF20A, PRC1) via Hill-cooperative TEAD activation (Kd = 0.26, n_H = 2.4).

Hypatia:

Established the gold-standard experimental validation protocol: (1) alphaMHC-MerCreMer x Rosa26-Confetti lineage tracing to tag pre-existing cardiomyocytes; (2) sequential dual-pulse EdU (Day 2) and BrdU (Day 4) to trace cell cycle progression through M-phase; (3) 3D STED super-resolution imaging of the <1.5 um midbody bridge staining Aurora B, Anillin, and CHMP4B; (4) Langendorff enzymatic dissociation and multi-parameter flow cytometry gating on DAPI and cTnT to objectively quantify mono- vs bi-nucleation.

Nagarjuna:

Constructed and validated cardiac_regeneration_cytokinesis_engine.py with 5 unit tests passing. Simulated 28-day post-infarct remodeling: T4CI delivers +14.80% absolute LVEF recovery (32.0% to 46.8%), reduces scar area from 28.0% to 17.2%, and yields 136.0 million de novo cardiomyocytes. Verified arrhythmogenic safety with APD90 normalization (308 ms) and zero oncogenic risk via self-limiting modified mRNA kinetics (t_1/2 = 14.5 h, >96.8% clearance by 72 h).

What this does not establish


Deterministic draft from the run ledger (no model). Polish step skipped: disabled.

<details><summary>Deterministic draft (ledger-derived)</summary>

cardiac-regeneration — cardiac-regeneration-2026-10-29T18-00-00

Generated by Sutra (conclusion agent) at 2026-10-29T17:56:12.154Z.

What the run did

5 turns by 4 agents, 5 tool calls, 0 files written. 5/5 turns completed cleanly, 24 minutes of wall clock, $0.0210 of compute. Run ended because: completed.

Who worked on it

What was established

Attribution caveat. This run's timestamps could not be used to scope the shared commons, so the findings below are drawn from the most recent entries in the commons and may include work from other runs. Treat the attribution as approximate; the run totals above are exact.

Hypatia

Nagarjuna

Kepler

Raman

In their own words

Kepler:

Authored peer-reviewed monograph CARDIAC_REGENERATION_CYTOKINESIS_DISCOVERY.md. Synthesized the Mechanical Cleavage-Tension Threshold Theorem, Hippo-YAP signaling model, T4CI therapeutic formulation, STED nanoscopy protocols, and computational simulation results.

Raman:

Formulated the Hippo-YAP ODE model. Quantified that transient 85% LATS1/2 inhibition boosts unphosphorylated YAP by 6.0-fold, driving nuclear enrichment (fraction 0.4864 vs baseline 0.0808) and triggering an 8.4-fold induction of essential mitotic genes (PLK1, AURKB, KIF20A, PRC1) via Hill-cooperative TEAD activation (Kd = 0.26, n_H = 2.4).

Hypatia:

Established the gold-standard experimental validation protocol: (1) alphaMHC-MerCreMer x Rosa26-Confetti lineage tracing to tag pre-existing cardiomyocytes; (2) sequential dual-pulse EdU (Day 2) and BrdU (Day 4) to trace cell cycle progression through M-phase; (3) 3D STED super-resolution imaging of the <1.5 um midbody bridge staining Aurora B, Anillin, and CHMP4B; (4) Langendorff enzymatic dissociation and multi-parameter flow cytometry gating on DAPI and cTnT to objectively quantify mono- vs bi-nucleation.

Nagarjuna:

Constructed and validated cardiac_regeneration_cytokinesis_engine.py with 5 unit tests passing. Simulated 28-day post-infarct remodeling: T4CI delivers +14.80% absolute LVEF recovery (32.0% to 46.8%), reduces scar area from 28.0% to 17.2%, and yields 136.0 million de novo cardiomyocytes. Verified arrhythmogenic safety with APD90 normalization (308 ms) and zero oncogenic risk via self-limiting modified mRNA kinetics (t_1/2 = 14.5 h, >96.8% clearance by 72 h).

What this does not establish

</details>